Peppermint leaves (Folia Menthae piperitae)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Spasmolytics myotropic

Included in the formulation
  • Peppermint leaves
    raw materials. inwards 
    IVAN-TEA, CJSC     Russia
  • Peppermint leaves
    raw materials. inwards 
    KRASNOHORSKILKLEKSSREDSTVA, JSC     Russia
  • Peppermint leaves
    raw materials. inwards 
    HEALTH OF THE FIRM, LLC     Russia
  • Peppermint leaves
    raw materials. inwards 
    KRASNOHORSKILKLEKSSREDSTVA, JSC     Russia
  • Peppermint peppermint
    tincture inwards 
    TVERSKAYA PHARMACEUTICAL FACTORY, OJSC     Russia
  • Peppermint peppermint
    tincture inwards 
    CAMELIA NPP, LLC     Russia
    • АТХ:

    A.03.A.X   Other drugs used in bowel disorders

    Pharmacodynamics:

    The drug has a sedative, choleretic, moderate spasmolytic, local irritant, antiemetic effect. When applying the drug to mucous membranes, it has a moderate analgesic effect.

    When ingested (under the tongue), menthol irritates the cold receptors of the oral mucosa, which stimulates the formation and release of enkephalins, endorphins, dinorphins and peptides that play an important role in regulating pain, permeability and vascular tone, in modulating various mediator systems. As a result, there is a reflex dilatation of the vessels of the heart, brain, and lungs. Menthol stimulates the respiratory center, suppresses the gag reflex.Menthol and other essential oil components have an antispasmodic effect on the smooth muscles of the gastrointestinal tract and urinary tract, gently stimulate the secretion of the digestive glands. Menthol in combination with flavonoids of mint leaves provides a choleretic effect. Esters of isovaleric acid provide a sedative effect.

    Menthol, beta-pinene, limonene, cineole, tannins and ursolic acid provide antimicrobial, antifungal effects and contribute to the restoration of the functions of the ciliated epithelium of the upper respiratory tract. Expectorant, mucolytic and moderate antihypoxic effects persist with mint oil inhalation.

    Pharmacokinetics:

    Not described.

    Indications:Vomiting, nausea. To improve the taste of medicine. In the composition of combined preparations as an auxiliary substance: increased excitability of the nervous system, neuroses, light sleep disorders; cardialgia, angina pectoris, cardiopsychoneurosis with tachycardia and hypertension; dyskinesias and spastic conditions of the digestive tract, fermentopathy, dysbiosis, meteorism, cholecystitis,cholelithiasis; Infectious-inflammatory diseases of the oral cavity and upper respiratory tract; sea ​​and air sickness, toxicosis; arthralgia, myalgia, neuralgia, sciatica, rheumatism, bruises; damage to the mucosa of the mouth and lips, toothache, sunburn of the lips.
    ICD-10

    V.F40-F48.F45.3   Somatoform dysfunction of the autonomic nervous system

    V.F40-F48.F48.0   Neurasthenia

    V.F50-F59.F51.2   Sleep and wakefulness disorder inorganic etiology

    VIII.H80-H83.H81   Violations of the vestibular function

    IX.I20-I25.I20   Angina pectoris [angina pectoris]

    X.J00-J06.J01   Acute Sinusitis

    X.J00-J06.J02   Acute pharyngitis

    X.J00-J06.J03   Acute tonsillitis

    X.J00-J06.J04   Acute laryngitis and tracheitis

    X.J30-J39.J31   Chronic rhinitis, nasopharyngitis and pharyngitis

    X.J30-J39.J32   Chronic Sinusitis

    X.J30-J39.J35.0   Chronic tonsillitis

    X.J30-J39.J37   Chronic laryngitis and laryngotracheitis

    XI.K00-K14.K08.8   Other specified changes in teeth and their supporting apparatus

    XI.K00-K14.K12   Stomatitis and related lesions

    XI.K55-K63.K63   Other bowel diseases

    XI.K80-K87.K80   Gallstone disease [cholelithiasis]

    XI.K80-K87.K81.0   Acute cholecystitis

    XI.K80-K87.K81.1   Chronic cholecystitis

    XIII.M20-M25.M25.5   Pain in the joint

    XIII.M50-M54.M54.1   Radiculopathy

    XIII.M70-M79.M79.1   Myalgia

    XIII.M70-M79.M79.2   Neuralgia and neuritis, unspecified

    XVIII.R10-R19.R14   Meteorism and related conditions

    Contraindications:

    Hypersensitivity, early childhood. Diabetes mellitus (for tablets).

    Carefully:

    Pregnancy and lactation.

    Pregnancy and lactation:

    The FDA category is not defined. There is no data on the effect of the drug in breastfeeding or pregnancy.

    Dosing and Administration:

    Locally as a rinse; orally, in the form of inhalation; externally, in the form of washing.

    Inside, in the form of infusion, 70-100 ml 2-3 times a day, 15 minutes before meals or 15 ml of peppermint water every 3 hours.

    To prepare the infusion 1 briquette or 1 tablespoon of crushed raw material (5 g) is placed in enameled ware, poured 200 ml of hot boiled water, covered with a lid and heated in a boiling water bath with frequent stirring for 15 minutes, cooled at room temperature for 45 minutes, filtered, the remaining raw material is squeezed. The volume of the infusion obtained is adjusted to 200 ml with boiled water.

    Filter packets: 2-3 filter packets are placed in glass or enameled dishes, pour 200 ml of boiling water, cover with a lid and insist for 20 minutes; the filter bags are squeezed out, the volume of the obtained infusion is brought to boiling water to 200 ml. Is taken orally, 15 ml (1 tablespoon) every 2-3 hours.

    Sublingually, 1-2 tablets.

    Tincture: inside, 10-15 drops per reception every 3 hours.

    Side effects:

    Allergic reactions, bronchospasm, respiratory depression, hyperemia, burning, rashes, irritation, nausea, dizziness.

    Overdose:

    Not described.

    Interaction:

    The drug enhances the effect of drugs that oppress the central nervous system, as well as antihypertensive drugs.

    Special instructions:

    Do not apply to damaged skin, avoid contact with eyes.

    Instructions
    Up